Sens. Elizabeth Warren, D-Mass., Cory Booker, D-N.J., and Ron Wyden, D-Ore., today urged the Food and Drug Administration to review how accurately pulse oximeters monitor blood oxygen levels, citing multiple studies suggesting they provide misleading measures to patients of color.

"In order to reduce health disparities and restore trust among communities of color, we must reevaluate the ways in which current practices and clinical tools themselves potentially worsen outcomes for people of color," the senators wrote. "With an ongoing pandemic disproportionately affecting communities of color, it can be a matter of life or death that the very device that could help these communities and their health care providers detect the need for urgent care is less likely to alert them to risks simply because of the color of their skin.”

Related News Articles

Blog
According to the CDC, 80% of pregnancy-related deaths can be prevented; that’s a 20% increase from previous years. Know why? That’s actually the theme for…
Headline
AHA today released its latest triennial report on governance structures and practices at U.S. hospitals and health systems, based on data from 933 hospital and…
Headline
The Centers for Disease Control and Prevention’s Division for Heart Disease and Stroke Prevention is working with NORC at the University of Chicago, AHA and…
Headline
The Centers for Medicare & Medicaid Services yesterday released guidance to clarify how states can use an existing Medicaid managed care option to reduce…
Headline
The latest AHA podcast on leading initiatives to transform care and advance equity looks at Jefferson Health’s success in expanding diversity at the…
Headline
Learn how New York’s Mount Sinai Health System took on the task of addressing its community’s health inequities while managing the myriad challenges brought on…